Jorn Drappa insider trades: Alumis (ALMS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jorn reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ALMS | ↓ Sell | 593 | $6.52 | $4K | Direct | Nov 4, 2026 (2d) |
| Aug 3, 2026 | ALMS | ↓ Sell | 2,447 | $26.37 | $65K | Direct | Aug 5, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALMS insiders
Open-market trades in the last 12 months
About Jorn Drappa's insider trades
Jorn Drappa is Chief Medical Officer at Alumis (ALMS). Since Aug 3, 2026, Jorn has reported no open-market purchases and 2 sales worth $68K on SEC Form 4. In the last 12 months: 2 sales ($68K).
Their filings also include grants and awards (9 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.